Table 1.
Patients | n | Age (years) | BMI | pH | Sperm volume | Sperm count (mil/ml) | Sperm motility (%) | Sperm morphology | Fructose (≥13 µmole/ejaculate) | Citric acid (≥13 μmole/ejaculate) | ROS |
---|---|---|---|---|---|---|---|---|---|---|---|
AS | 22 | 34.8±4.9 | 25.2±3.9 | 7.5±0.5 | 1.8±0.9 | 39.6±3.5* | 20.5±6.3* | 30.6±3.5 | 52.2±11.2* | 38.6±6.9* | 159±61.7* |
AZ | 17 | 34.2±6.3 | 26.3±3.5 | 7.6±0.5 | 1.7±0.7 | 0.00±0.0* | 0.00±0.0* | 0.00±0.0 | 129±5.4 | 32.7±3.5* | 0.00±0.0* |
ID | 21 | 36.3±5.2 | 25.7±4.3 | 7.5±1.7 | 2.8±1.5 | 59.9±23.4* | 57.7±15.4 | 46.1±9.01 | 126.9±6.9* | 53.28±10.2 | 114±45.7 |
OL | 12 | 34.3±6.5 | 26±3.4 | 7.6±0.5 | 2.1±1.3 | 9.4±3.9* | 57.4±16 | 42.6±4.8 | 111±8.5* | 38.7±6.4* | 160±66.5* |
OA | 14 | 34±5.6 | 27.1±3.5 | 7.6±0.4 | 2.6±1.1 | 8.5±2.5* | 13.5±10.2* | 41±6.6 | 108±6.5* | 41.2±8.1 | 248±67.3* |
AT | 2 | 37.5±0.7 | 28.4±6.0 | 8±0.7 | 3.7±3.1 | 45±21.2* | 25±0.00* | 18±1.4 | 115±7.7 | 41±11.3 | 216±94* |
OAT | 4 | 31.2±3.3 | 24±1.4 | 7.6±0.7 | 2.4±1.7 | 5.5±3.3* | 13.5±7.6* | 12.2±4 | 129±14.8 | 44±13.9 | 245±98* |
OT | 5 | 31.8±3.8 | 26.8±3.1 | 7.8±0.3 | 1.6±1.4 | 9.4±1.9* | 65±7.07* | 17.2±3.9 | 164±15.2* | 22.8±8.1* | 212±67* |
T | 3 | 35.3±11 | 25.8±1.2 | 7.5±0.8 | 2.4±1.9 | 50±20* | 46.6±11.5* | 15±3.6 | 137±17* | 45±6.02 | 265±50* |
Control | 50 | 32.5±3.2 | 25±2.1 | 7.5±0.1 | 2.3±0.2 | 68.7±6.3* | 54.2±1.9 | 30.1±2.1 | 126.4±4.6 | 49.4±1.2 | 71.4±4.0 |
*P<0.05 defines the level of significance. All values are presented as mean±SD. SD=Standard deviation, AS=Asthenozoospermia, AZ=Azoospermia, ID=Idiopathic, OA=Oligoasthenozoospermia, AT=Astenoteratozoospermia, OL=Oligozoospermia, T=Teratozoospermia, ROS=Reactive oxidation species, BMI=Body mass index